Allarity Therapeutics (ALLR) Operating Leases (2020 - 2022)
Allarity Therapeutics' (ALLR) quarterly Operating Leases came in at $8000.0 in Q4 2022, down 11.11% YoY from $9000.0 in Q4 2021, and down 11.11% on a QoQ basis from $9000.0 in Q4 2021.
Allarity Therapeutics (ALLR) Operating Leases (2020 - 2022) Analysis & Trends
Allarity Therapeutics (ALLR) has 3 years of Operating Leases data on file, last reported at $8000.0 in Q4 2022.
- Quarterly Operating Leases fell 11.11% year-over-year to $8000.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $8000.0 (down 11.11% YoY) and the FY2022 annual result came in at $8000.0, down 11.11% from the prior year.
- Operating Leases eased to $8000.0 in Q4 2022, from $9000.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $376000.0 in Q4 2020 to a low of $8000.0 in Q4 2022.
- A 3-year average of $107000.0 and a median of $22000.0 in 2021 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2021 — Operating Leases slumped 97.61% — and 2022, when it slipped 11.11%.
- Tracing ALLR's Operating Leases over 3 years: stood at $376000.0 in 2020, then tumbled by 97.61% to $9000.0 in 2021, then retreated by 11.11% to $8000.0 in 2022.
- The last three Operating Leases figures came in at $8000.0 (Q4 2022), $9000.0 (Q4 2021), and $35000.0 (Q3 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Allarity Therapeutics | 23.23 Mn | 23.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 8,000.00 |
| Dec 31, 2021 | 9,000.00 |
| Sep 30, 2021 | 35,000.00 |
| Dec 31, 2020 | 376,000.00 |